Holland-Hart, Daniella ORCID: https://orcid.org/0000-0002-1127-5152, Carucci, Margherita, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Longo, Mirella ORCID: https://orcid.org/0000-0002-9867-3806, Campbell, Susan, Irving, Alys, Noble, Simon ORCID: https://orcid.org/0000-0001-5425-2383, Jayson, Gordon and Hopewell-Kelly, Noreen
2025.
Participants’ perspectives of the advanced ovarian cancer biomarker study VALTIVE1: a qualitative study.
BMJ Open
15
(7)
, e088474.
10.1136/bmjopen-2024-088474
|
|
|
Carucci, Margherita, Clamp, Andrew, Zhou, Cong, Hurt, Chris, Glasspool, Rosalind, Monaghan, Phillip J., Thirkettle, Sally, Wheatley, Michael, Mahmood, Madia, Narasimham, Monica, Cox, Tracy, Morrison, Hilary, Campbell, Susan, Nelson, Annmarie, Holland-Hart, Daniella ORCID: https://orcid.org/0000-0002-1127-5152, Hopewell-Kelly, Noreen, Thomas, Abin, Porter, Catharine, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Irving, Alys, Dive, Caroline, Adams, Richard and Jayson, Gordon C.
2024.
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.
BMC Cancer
24
(1)
, 1309.
10.1186/s12885-024-13073-0
|
|
|
Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Serpi, Michaela ORCID: https://orcid.org/0000-0002-6162-7910, Ghazaly, Essam, Kariuki, Benson M. ORCID: https://orcid.org/0000-0002-8658-3897, McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X and Pepper, Chris
2021.
Single diastereomers of the clinical anticancer ProTide agents NUC-1031 and NUC-3373 preferentially target cancer stem cells in vitro.
Journal of Medicinal Chemistry
64
(12)
, pp. 8179-8193.
10.1021/acs.jmedchem.0c02194
|
|
|
| NuCana PLC 2021. Phosphoramidate nucleoside derivatives as anticancer agents. WO2017207986A1; US20210130387A1. [Patent]. |
|
Bassetto, Marcella ORCID: https://orcid.org/0000-0002-2491-5868 and Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190
2019.
Therapeutic use of fluorinated nucleosides – progress in patents.
Pharmaceutical Patent Analyst
7
(6)
, p. 277.
10.4155/ppa-2018-0028
|
|
|
Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Ferrari, Valentina ORCID: https://orcid.org/0000-0003-1895-8906, Serpi, Michaela ORCID: https://orcid.org/0000-0002-6162-7910, Gonczy, Blanka, Balzarini, Jan and McGuigan, Christopher
2018.
Symmetrical diamidates as a class of phosphate prodrugs to deliver the 5'-monophosphate form of anticancer nucleoside analogues.
ChemMedChem
13
(21)
, pp. 2305-2316.
10.1002/cmdc.201800504
|
|
|
Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Ferla, Salvatore ORCID: https://orcid.org/0000-0002-5918-9237, Brancale, Andrea ORCID: https://orcid.org/0000-0002-9728-3419 and McGuigan, Christopher
2018.
Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides.
Bioorganic and Medicinal Chemistry
26
(3)
, pp. 551-565.
10.1016/j.bmc.2017.11.037
|
|
|
| NuCana Biomed Ltd 2017. Adenosine derivatives for use in the treatment of cancer. WO2017207989A1. [Patent]. |
|
Cavaliere, Alessandra, Probst, Katrin, Westwell, Andrew ORCID: https://orcid.org/0000-0002-5166-9236 and Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190
2017.
Fluorinated nucleosides as an important class of anticancer and antiviral agents.
Future Medicinal Chemistry
9
(15)
|
|
|
Serpi, Michaela ORCID: https://orcid.org/0000-0002-6162-7910, De Biasi, Roberto, Pertusati, Fabrizio ORCID: https://orcid.org/0000-0003-4532-9101, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190 and McGuigan, Christopher
2017.
Synthetic approaches for the preparation of phosphoramidate prodrugs of 2’-deoxypseudoisocytidine.
ChemistryOpen
6
(3)
, pp. 424-436.
10.1002/open.201700019
|
|
|
McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Serpi, Michaela ORCID: https://orcid.org/0000-0002-6162-7910, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Ferrari, Valentina ORCID: https://orcid.org/0000-0003-1895-8906, Pertusati, Fabrizio ORCID: https://orcid.org/0000-0003-4532-9101, Meneghesso, Silvia, Derudas, Marco, Farleigh, Laura, Zanetta, Paola and Bugert, Joachim ORCID: https://orcid.org/0000-0002-0556-3211
2016.
Anti-flavivirus activity of different tritylated pyrimidine and purine nucleoside analogues.
ChemistryOpen
5
(3)
, pp. 227-235.
10.1002/open.201500216
|
|
|
| NuCana PLC 2015. Gemcitabine Prodrugs. WO 2015/198058; GB51857. [Patent]. |
|
Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Huerta Lopez, Monica, Balzarini, Jan, Mason, Malcolm ORCID: https://orcid.org/0000-0003-1505-2869, Jiang, Wen G. ORCID: https://orcid.org/0000-0002-3283-1111, Blagden, Sarah, Thompson, Emely, Ghazaly, Essam and McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X
2014.
Application of ProTide technology to Gemcitabine: A successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development.
Journal of Medicinal Chemistry
57
(4)
, pp. 1531-1542.
10.1021/jm401853a
|
|
|
| Magdalena Slusarczyk 2014. Prodrug. IN 2014MU02050. [Patent]. |
|
McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Bourdin, Claire, Derudas, Marco, Hamon, Nadege, Hinsinger, Karen, Kandil, Sahar ORCID: https://orcid.org/0000-0003-1806-9623, Madela, Karolina, Meneghesso, Silvia, Pertusati, Fabrizio ORCID: https://orcid.org/0000-0003-4532-9101, Serpi, Michaela ORCID: https://orcid.org/0000-0002-6162-7910, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Chamberlain, Stanley, Kolykhalov, Alexander, Vernachio, John, Vanpouille, Christophe, Introini, Andrea, Margolis, Leonid and Balzarini, Jan
2013.
Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
European Journal of Medicinal Chemistry
70
, pp. 326-340.
10.1016/j.ejmech.2013.09.047
|
|
|
Ghazaly, Essam Ahmed, Joel, Simon, Gribben, John G., Mohammad, Tariq, Emiloju, Oluwadunni, Stavraka, Chara, Hopkins, Tom, Gabra, Hani, Wasan, Harpreet, Habib, Nagy A., Leonard, Robert C. F., McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190 and Blagden, Sarah Patricia
2013.
ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors [Abstract].
Journal of Clinical Oncology
31
(15)
, abstr. 2576.
|
|
| Nucana Biomed Ltd 2012. Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer. WO 2012117246 A1 20120907. [Patent]. |
|
McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Murziani, Paola, Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, Gonczy, Blanka, Vande Voorde, Johan, Liekens, Sandra and Balzarini, Jan
2011.
Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside.
Journal of Medicinal Chemistry
54
(20)
, pp. 7247-7258.
10.1021/jm200815w
|
|
Voorde, J. V., Liekens, S., McGuigan, Christopher ORCID: https://orcid.org/0000-0001-8409-710X, Murziani, Paola G. S., Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190 and Balzarini, J.
2011.
The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2 '-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Biochemical Pharmacology
82
(5)
, pp. 441-452.
10.1016/j.bcp.2011.05.024
|
|
Slusarczyk, Magdalena ORCID: https://orcid.org/0000-0002-4707-7190, De Borggraeve, Wim M., Hoornaert, Georges, Deroose, Frederik and Linders, Joannes T. M.
2008.
Synthesis and biological evaluation of methylene-bridged analogs of the potent cannabinoid receptor antagonist rimonabant.
European Journal of Organic Chemistry
2008
(8)
, pp. 1350-1357.
10.1002/ejoc.200700960
|
|



Up a level